Detalhe da pesquisa
1.
Bioactivity guided fractionation of methanolic extract of Terminalia arjuna for its CYP3A and CYP2D inhibition in rat liver microsomes.
Biopharm Drug Dispos
; 39(3): 143-151, 2018 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-29327455
2.
Investigation of CYP3A4 and CYP2D6 Interactions of Withania somnifera and Centella asiatica in Human Liver Microsomes.
Phytother Res
; 29(5): 785-90, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25684704
3.
In vitro evaluation of hepatic and extra-hepatic metabolism of coumarins using rat subcellular fractions: correlation of in vitro clearance with in vivo data.
Drug Metabol Drug Interact
; 23(3-4): 329-50, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-19326776
4.
In Vitro CYP2D Inhibitory Effect and Influence on Pharmacokinetics and Pharmacodynamic Parameters of Metoprolol Succinate by Terminalia arjuna in Rats.
Drug Metab Lett
; 10(2): 124-35, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26891872
5.
In vitro assessment of CYP1A2 and 2C9 inhibition potential of Withania somnifera and Centella asiatica in human liver microsomes.
Drug Metab Pers Ther
; 30(2): 137-41, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25938222
6.
In vitro modulatory effects of Terminalia arjuna, arjunic acid, arjunetin and arjungenin on CYP3A4, CYP2D6 and CYP2C9 enzyme activity in human liver microsomes.
Toxicol Rep
; 2: 806-816, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-28962416
7.
In vitro and in vivo Evaluation of CYP1A Interaction Potential of Terminalia Arjuna Bark.
Indian J Pharm Sci
; 76(2): 138-47, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24843187